Anzemet

Company: Hoechst Marion Roussel
Approval Status: Approved September 1997
Treatment for: Treatment for chemotherapy induced emesis
Areas: Cancer & Oncology
Possible similar drugs: Anzemet

| General Information |

General Information

Anzemet has been approved for the prevention of chemotherapy-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.

< back to top

Anzemet Drug Information

The Anzemet drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.